30
Participants
Start Date
January 31, 2014
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2014
LSIB + SSNB
Patients will receive LSIB (31 ml ropivacaine 7.5 mg/ml)+ SSNB (4 ml Ropivacaine 5 mg/ml) or LSIB (31 ml ropivacaine 7.5 mg/ml)+ SSNB (4 ml placebo, saline)
University Hospital of North Norway, Tromsø
University of Tromso
OTHER
University Hospital of North Norway
OTHER